2007 SABCS General Views and speakers
Read More
San Antonio, TX -SABCS 2007: Stephen Jones of presents a paper on ?Extended follow-up and analysis by age of the US Oncology Adjuvant trial 9735: docetaxel/cyclophosphamide is associated with an overall survival benefit compared to doxorubicin/cyclophosphamide and is well-tolerated in women 65 or older? during the General Session 1 at the San Antonio Breast Cancer Symposium here today, Thursday December 13, 2007 in the Henry Gonzalez Convention Center. Over 8,000 physicians, researchers, clinicians, caregivers and cancer survivors from over 60 countries gathered to hear the latest developments in Breast Cancer research and treatment. Date: Thursday December 13, 2007 Photo by © SABCS/Todd Buchanan 2007 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154.
